[Form 4] Insulet Corporation Insider Trading Activity

Rhea-AI Filing Summary

Insulet Corporation insider report: Prem Singh, SVP, Global Operations, reported multiple equity transactions dated 08/07/2025 involving common stock and stock options of Insulet (PODD). The Form 4 shows two acquisitions of common stock for 585 shares at $264.69 and 758 shares at $276.36, and a disposition of 1,343 shares sold at $320. The filing states these transactions were effected under an existing Rule 10b5-1 trading plan. The report also discloses annual non-qualified stock option awards: 585 options at a $264.69 exercise price (expiring 02/28/2032) and 758 options at a $276.36 exercise price (expiring 02/28/2033), each vesting in substantially equal installments over four years. The document lists line-by-line beneficial ownership figures corresponding to each transaction.

Positive

• Transactions executed under a Rule 10b5-1 trading plan, which provides a pre-established framework for insider trades.
• Receipt of annual non-qualified stock option awards for 585 and 758 options with disclosed exercise prices and expirations.
• Detailed exercise-price and vesting disclosure (options vest in substantially equal installments over four years), which improves transparency.

Negative

• Disposition of 1,343 shares at $320 reduced the reporting person's direct holdings to the per-line reported level of 4,143 shares.

Insights

Financial Analyst

TL;DR: Insider activity shows option grants and offsetting purchases and a sale under a 10b5-1 plan; transactions are informational but not clearly material alone.

The filing reports on 08/07/2025 two share acquisitions (585 and 758 shares) and a sale of 1,343 shares, with corresponding exercise-price information and per-line beneficial ownership figures. The acquisitions and disposition aggregate to equal share counts (1,343 acquired vs 1,343 sold), and the awards are labeled as annual non-qualified options with multi-year vesting and expirations in 2032 and 2033. Because these actions occurred pursuant to a Rule 10b5-1 plan and include standard annual option grants, they are routine disclosures that provide transparency on executive compensation and trading activity but do not by themselves change valuation metrics.

Corporate Governance Expert

TL;DR: Use of a 10b5-1 plan and annual option awards is standard governance practice; vesting and expiration details are disclosed.

The Form 4 confirms the reporting person received annual non-qualified stock options and executed transactions under a pre-existing Rule 10b5-1 plan, which helps mitigate concerns about opportunistic timing. The option awards are disclosed with exercise prices, expiry dates, and a four-year installment vesting schedule, which is typical for executive compensation. The filing was executed by an authorized attorney-in-fact, indicating delegated signing authority for the reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singh Prem

(Last) (First) (Middle)

C/O INSULET CORPORATION

100 NAGOG PARK

(Street)

ACTON MA 01720

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Global Operations

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2025		M(1)		585	A	$264.69	4,728	D
Common Stock	08/07/2025		M(1)		758	A	$276.36	5,486	D
Common Stock	08/07/2025		S(1)		1,343	D	$320	4,143	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$264.69	08/07/2025		M			585	(2)	02/28/2032	Common Stock	585	$0	195	D
Employee Stock Option (Right to Buy)	$276.36	08/07/2025		M			758	(2)	02/28/2033	Common Stock	758	$0	759	D

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

2. Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

	/s/ Patricia K. Dolan, attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Prem Singh report on Form 4 for Insulet (PODD)?

Two acquisitions of common stock for 585 shares at $264.69 and 758 shares at $276.36, plus a sale of 1,343 shares at $320 (all dated 08/07/2025).

Were the trades by the Insulet insider part of a trading plan?

Yes. The Form 4 states the transactions were effected pursuant to an existing Rule 10b5-1 trading plan.

Did the filing disclose any stock option awards for Prem Singh?

Yes. Annual non-qualified stock option awards for 585 options at $264.69 (expiring 02/28/2032) and 758 options at $276.36 (expiring 02/28/2033), vesting in equal installments over four years.

What is the net count of shares involved in the reported transactions?

Acquisitions total 1,343 shares (585 + 758) and the reported disposition is 1,343 shares sold, as shown on the Form 4 lines.

Who signed the Form 4 filing for the reporting person?

The form was executed by Patricia K. Dolan as attorney-in-fact for the reporting person, as indicated on the document.